Skip to content

Medical-device intelligence

Syva Co., Dade Behring, Inc.: FDA clearances and recalls

Research Syva Co., Dade Behring, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

19 clearance records and 0 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Mar 27, 2000 to Jul 2, 2001.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

19 matching records
Device / recordCompany in FDA recordSourceSource date
EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229K011920 · KXTSyva Co., Dade Behring, Inc.510(k)Jul 2, 2001FDA decision date
EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229K011620 · LANSyva Co., Dade Behring, Inc.510(k)Jun 18, 2001FDA decision date
EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229K011605 · LBZSyva Co., Dade Behring, Inc.510(k)Jun 12, 2001FDA decision date
EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229K011300 · LDJSyva Co., Dade Behring, Inc.510(k)May 17, 2001FDA decision date
EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229K011306 · JXMSyva Co., Dade Behring, Inc.510(k)May 16, 2001FDA decision date
MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229K011161 · LCMSyva Co., Dade Behring, Inc.510(k)May 15, 2001FDA decision date
EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229K011289 · DJGSyva Co., Dade Behring, Inc.510(k)May 15, 2001FDA decision date
MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229K011163 · JXNSyva Co., Dade Behring, Inc.510(k)May 10, 2001FDA decision date
MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229K011164 · KXSSyva Co., Dade Behring, Inc.510(k)May 10, 2001FDA decision date
MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229K011166 · KLSSyva Co., Dade Behring, Inc.510(k)May 10, 2001FDA decision date
MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAYK011162 · DIOSyva Co., Dade Behring, Inc.510(k)May 2, 2001FDA decision date
EMIT II PLUS ETHYL ALCOHOL ASSAY, MODEL OSR9K229K010960 · DICSyva Co., Dade Behring, Inc.510(k)Apr 26, 2001FDA decision date
EMIT II PLUS METHADONE ASSAY, MODEL OSRE229K010962 · DJRSyva Co., Dade Behring, Inc.510(k)Apr 26, 2001FDA decision date
EMIT II PLUS BARBITUATE ASSAY, MODEL 0SR9D0229K010934 · DISSyva Co., Dade Behring, Inc.510(k)Apr 20, 2001FDA decision date
EMIT 2000 GENTAMICIN PLUS ASSAYK010984 · LCDSyva Co., Dade Behring, Inc.510(k)Apr 20, 2001FDA decision date
EMIT 2000 PROCAINAMIDE ASSAY, MODEL OSR4K229K010812 · LARSyva Co., Dade Behring, Inc.510(k)Apr 13, 2001FDA decision date
EMIT 2000 CARBAMAZEPINE ASSAY, MODEL OSR4F229K010814 · KLTSyva Co., Dade Behring, Inc.510(k)Apr 13, 2001FDA decision date
EMIT 2000 TOBRAMYCIN ASSAY EMIT 2000 TOBRAMYCIN CALIBRATORSK003341 · KLBSyva Co., Dade Behring, Inc.510(k)Jan 22, 2001FDA decision date
SYVA EMIT 2000 THYROXINE ASSAY, CALIBRATORSK000600 · KLISyva Co., Dade Behring, Inc.510(k)Mar 27, 2000FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗